Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "033176-2024",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 2,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "2",
"value": 2,
"measure": "bids",
"relatedLot": "2"
},
{
"id": "3",
"value": 2,
"measure": "bids",
"relatedLot": "3"
},
{
"id": "4",
"value": 2,
"measure": "bids",
"relatedLot": "4"
},
{
"id": "5",
"value": 3,
"measure": "bids",
"relatedLot": "5"
}
]
},
"date": "2024-10-15T15:14:18+01:00",
"ocid": "ocds-h6vhtk-03e155",
"buyer": {
"id": "GB-NHS-Y56",
"name": "NHS England"
},
"awards": [
{
"id": "033176-2024-1",
"title": "North West London",
"status": "active",
"suppliers": [
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited"
}
],
"relatedLots": [
"1"
]
},
{
"id": "033176-2024-2",
"title": "North Central London",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-127092",
"name": "North Middlesex University Hospital NHS Trust"
}
],
"relatedLots": [
"2"
]
},
{
"id": "033176-2024-3",
"title": "North East London",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-127093",
"name": "Homerton University Hospital Foundation Trust"
}
],
"relatedLots": [
"3"
]
},
{
"id": "033176-2024-4",
"title": "South East London",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-9768",
"name": "Guy's and St Thomas' NHS Foundation Trust"
}
],
"relatedLots": [
"4"
]
},
{
"id": "033176-2024-5",
"title": "South West London",
"status": "active",
"suppliers": [
{
"id": "GB-COH-09297203",
"name": "NEC Software Solutions UK Limited"
}
],
"relatedLots": [
"5"
]
}
],
"tender": {
"id": "PRJ1238",
"lots": [
{
"id": "1",
"title": "North West London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\")was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
},
{
"id": "2",
"title": "North Central London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
},
{
"id": "3",
"title": "North East London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
},
{
"id": "4",
"title": "South East London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
},
{
"id": "5",
"title": "South West London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "5",
"relatedLot": "5",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
}
],
"title": "NHS Diabetic Eye Screening Programme London Region",
"status": "complete",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "The award notice concerns the procurement of 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.\nThis will be achieved by delivering an evidence-based service that:\n•Identifies the eligible population and ensures effective delivery with maximum coverage.\n•Is safe, effective, high quality, externally and independently monitored, and quality assured.\n•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.\n•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.\n•Has audit embedded in the service.\n•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.\nThere are 3 key elements of service delivery, namely:\n•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.\n•Digital surveillance where individuals need more frequent screening.\n•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts). \nOptical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance. \nThe Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.\nThe 7-year estimated contract values, based on predicted activity levels, are:\nLot 1 = £33,703,069, Lot 2 = £18,930,476, Lot 3 = £28,062,012, Lot 4 = £21,533,552, Lot 5 = £18,120,336 \nPlease note, the full indicative contract values per each financial year can be found in the tender documentation.",
"classification": {
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
},
"procurementMethod": "open",
"mainProcurementCategory": "services",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NHS-Y56",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI",
"locality": "Leeds",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom",
"streetAddress": "Quarry House, Quarry Hill"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"id": "Y56",
"scheme": "GB-NHS",
"legalName": "NHS England"
},
"contactPoint": {
"name": "Khadijah Yasmin",
"email": "khadijah.yasmin@nhs.net"
}
},
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "High Wycombe",
"postalCode": "HP11 1JL",
"countryName": "United Kingdom",
"streetAddress": "Beechwood Hall, Kingsmead Road"
},
"identifier": {
"id": "03257228",
"scheme": "GB-COH",
"legalName": "InHealth Intelligence Limited"
}
},
{
"id": "GB-FTS-127092",
"name": "North Middlesex University Hospital NHS Trust",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "London,",
"postalCode": "N18 1QX",
"countryName": "United Kingdom",
"streetAddress": "Sterling Way,"
},
"identifier": {
"legalName": "North Middlesex University Hospital NHS Trust",
"noIdentifierRationale": "notOnAnyRegister"
}
},
{
"id": "GB-FTS-127093",
"name": "Homerton University Hospital Foundation Trust",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "London",
"postalCode": "E9 6SR",
"countryName": "United Kingdom",
"streetAddress": "Homerton Row"
},
"identifier": {
"legalName": "Homerton University Hospital Foundation Trust",
"noIdentifierRationale": "notOnAnyRegister"
}
},
{
"id": "GB-FTS-9768",
"name": "Guy's and St Thomas' NHS Foundation Trust",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "London",
"postalCode": "SE1 9RT",
"countryName": "United Kingdom",
"streetAddress": "Great Maze Pond"
},
"identifier": {
"legalName": "Guy's and St Thomas' NHS Foundation Trust",
"noIdentifierRationale": "notOnAnyRegister"
}
},
{
"id": "GB-COH-09297203",
"name": "NEC Software Solutions UK Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "Hertfordshire",
"postalCode": "HP2 7DX",
"countryName": "United Kingdom",
"streetAddress": "BizSpace, 1st Floor, iMex Centre, 575-599 Maxted Road, Hemel Hempstead,"
},
"identifier": {
"id": "09297203",
"scheme": "GB-COH",
"legalName": "NEC Software Solutions UK Limited"
}
}
],
"language": "en",
"contracts": [
{
"id": "033176-2024-1",
"title": "North West London",
"value": {
"amount": 32719770,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-1"
},
{
"id": "033176-2024-2",
"title": "North Central London",
"value": {
"amount": 18384296,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-2"
},
{
"id": "033176-2024-3",
"title": "North East London",
"value": {
"amount": 28017330,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-3"
},
{
"id": "033176-2024-4",
"title": "South East London",
"value": {
"amount": 20912350,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-4"
},
{
"id": "033176-2024-5",
"title": "South West London",
"value": {
"amount": 17124945,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-5"
}
],
"description": "Contract values are based on 24/25 excluding 2.93% uplift for AfC.",
"initiationType": "tender"
}Complete JSON history (4 releases)
15 Oct 2024 · 033176-2024 · award, contract
{
"id": "033176-2024",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 2,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "2",
"value": 2,
"measure": "bids",
"relatedLot": "2"
},
{
"id": "3",
"value": 2,
"measure": "bids",
"relatedLot": "3"
},
{
"id": "4",
"value": 2,
"measure": "bids",
"relatedLot": "4"
},
{
"id": "5",
"value": 3,
"measure": "bids",
"relatedLot": "5"
}
]
},
"date": "2024-10-15T15:14:18+01:00",
"ocid": "ocds-h6vhtk-03e155",
"buyer": {
"id": "GB-NHS-Y56",
"name": "NHS England"
},
"awards": [
{
"id": "033176-2024-1",
"title": "North West London",
"status": "active",
"suppliers": [
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited"
}
],
"relatedLots": [
"1"
]
},
{
"id": "033176-2024-2",
"title": "North Central London",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-127092",
"name": "North Middlesex University Hospital NHS Trust"
}
],
"relatedLots": [
"2"
]
},
{
"id": "033176-2024-3",
"title": "North East London",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-127093",
"name": "Homerton University Hospital Foundation Trust"
}
],
"relatedLots": [
"3"
]
},
{
"id": "033176-2024-4",
"title": "South East London",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-9768",
"name": "Guy's and St Thomas' NHS Foundation Trust"
}
],
"relatedLots": [
"4"
]
},
{
"id": "033176-2024-5",
"title": "South West London",
"status": "active",
"suppliers": [
{
"id": "GB-COH-09297203",
"name": "NEC Software Solutions UK Limited"
}
],
"relatedLots": [
"5"
]
}
],
"tender": {
"id": "PRJ1238",
"lots": [
{
"id": "1",
"title": "North West London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\")was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
},
{
"id": "2",
"title": "North Central London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
},
{
"id": "3",
"title": "North East London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
},
{
"id": "4",
"title": "South East London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
},
{
"id": "5",
"title": "South West London",
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") was seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy."
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "5",
"relatedLot": "5",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
}
],
"title": "NHS Diabetic Eye Screening Programme London Region",
"status": "complete",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "The award notice concerns the procurement of 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.\nThis will be achieved by delivering an evidence-based service that:\n•Identifies the eligible population and ensures effective delivery with maximum coverage.\n•Is safe, effective, high quality, externally and independently monitored, and quality assured.\n•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.\n•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.\n•Has audit embedded in the service.\n•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.\nThere are 3 key elements of service delivery, namely:\n•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.\n•Digital surveillance where individuals need more frequent screening.\n•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts). \nOptical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance. \nThe Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.\nThe 7-year estimated contract values, based on predicted activity levels, are:\nLot 1 = £33,703,069, Lot 2 = £18,930,476, Lot 3 = £28,062,012, Lot 4 = £21,533,552, Lot 5 = £18,120,336 \nPlease note, the full indicative contract values per each financial year can be found in the tender documentation.",
"classification": {
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
},
"procurementMethod": "open",
"mainProcurementCategory": "services",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NHS-Y56",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI",
"locality": "Leeds",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom",
"streetAddress": "Quarry House, Quarry Hill"
},
"details": {
"url": "https://www.england.nhs.uk/",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"id": "Y56",
"scheme": "GB-NHS",
"legalName": "NHS England"
},
"contactPoint": {
"name": "Khadijah Yasmin",
"email": "khadijah.yasmin@nhs.net"
}
},
{
"id": "GB-COH-03257228",
"name": "InHealth Intelligence Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "High Wycombe",
"postalCode": "HP11 1JL",
"countryName": "United Kingdom",
"streetAddress": "Beechwood Hall, Kingsmead Road"
},
"identifier": {
"id": "03257228",
"scheme": "GB-COH",
"legalName": "InHealth Intelligence Limited"
}
},
{
"id": "GB-FTS-127092",
"name": "North Middlesex University Hospital NHS Trust",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "London,",
"postalCode": "N18 1QX",
"countryName": "United Kingdom",
"streetAddress": "Sterling Way,"
},
"identifier": {
"legalName": "North Middlesex University Hospital NHS Trust",
"noIdentifierRationale": "notOnAnyRegister"
}
},
{
"id": "GB-FTS-127093",
"name": "Homerton University Hospital Foundation Trust",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "London",
"postalCode": "E9 6SR",
"countryName": "United Kingdom",
"streetAddress": "Homerton Row"
},
"identifier": {
"legalName": "Homerton University Hospital Foundation Trust",
"noIdentifierRationale": "notOnAnyRegister"
}
},
{
"id": "GB-FTS-9768",
"name": "Guy's and St Thomas' NHS Foundation Trust",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "London",
"postalCode": "SE1 9RT",
"countryName": "United Kingdom",
"streetAddress": "Great Maze Pond"
},
"identifier": {
"legalName": "Guy's and St Thomas' NHS Foundation Trust",
"noIdentifierRationale": "notOnAnyRegister"
}
},
{
"id": "GB-COH-09297203",
"name": "NEC Software Solutions UK Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "Hertfordshire",
"postalCode": "HP2 7DX",
"countryName": "United Kingdom",
"streetAddress": "BizSpace, 1st Floor, iMex Centre, 575-599 Maxted Road, Hemel Hempstead,"
},
"identifier": {
"id": "09297203",
"scheme": "GB-COH",
"legalName": "NEC Software Solutions UK Limited"
}
}
],
"language": "en",
"contracts": [
{
"id": "033176-2024-1",
"title": "North West London",
"value": {
"amount": 32719770,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-1"
},
{
"id": "033176-2024-2",
"title": "North Central London",
"value": {
"amount": 18384296,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-2"
},
{
"id": "033176-2024-3",
"title": "North East London",
"value": {
"amount": 28017330,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-3"
},
{
"id": "033176-2024-4",
"title": "South East London",
"value": {
"amount": 20912350,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-4"
},
{
"id": "033176-2024-5",
"title": "South West London",
"value": {
"amount": 17124945,
"currency": "GBP"
},
"status": "active",
"awardID": "033176-2024-5"
}
],
"description": "Contract values are based on 24/25 excluding 2.93% uplift for AfC.",
"initiationType": "tender"
}14 Sept 2023 · 027250-2023 · tenderUpdate
{
"id": "027250-2023",
"tag": [
"tenderUpdate"
],
"date": "2023-09-14T16:33:24+01:00",
"ocid": "ocds-h6vhtk-03e155",
"buyer": {
"id": "GB-NHS-Y56",
"name": "NHS England"
},
"tender": {
"id": "PRJ1238",
"title": "NHS Diabetic Eye Screening Programme London Region",
"amendments": [
{
"id": "2",
"unstructuredChanges": [
{
"where": {
"label": "Time limit for receipt of tenders or requests to participate",
"section": "IV.2.2"
},
"newValue": {
"date": "2023-09-21T12:00:00+01:00"
},
"oldValue": {
"text": ""
}
},
{
"where": {
"label": "Short description",
"section": "II.1.4"
},
"newValue": {
"text": "NHS England (London Region) (hereafter referred to as \"the Authority\") is seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.\nThis will be achieved by delivering an evidence-based service that:\n•Identifies the eligible population and ensures effective delivery with maximum coverage.\n•Is safe, effective, high quality, externally and independently monitored, and quality assured.\n•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.\n•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.\n•Has audit embedded in the service.\n•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.\nThere are 3 key elements of service delivery, namely:\n•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.\n•Digital surveillance where individuals need more frequent screening.\n•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).\nOptical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance.\nThe Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.\nThe 7-year estimated contract values, based on predicted activity levels, are:\nLot 1 = £33,703,069, Lot 2 = £18,930,476, Lot 3 = £28,062,012, Lot 4 = £21,533,552, Lot 5 = £18,120,336\nPlease note, the full indicative contract values per each financial year can be found in the tender documentation."
},
"oldValue": {
"text": ""
}
},
{
"where": {
"label": "Estimated value",
"section": "II.2.6"
},
"newValue": {
"text": "Value excluding VAT: £18,930,476"
},
"oldValue": {
"text": ""
},
"relatedLot": "Lot 2"
},
{
"where": {
"label": "Estimated Value",
"section": "II.2.6"
},
"newValue": {
"text": "Value excluding VAT: £28,062,012"
},
"oldValue": {
"text": ""
},
"relatedLot": "3"
}
]
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") is seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). \nThe eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.\nThis will be achieved by delivering an evidence-based service that:\n•Identifies the eligible population and ensures effective delivery with maximum coverage.\n•Is safe, effective, high quality, externally and independently monitored, and quality assured.\n•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.\n•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.\n•Has audit embedded in the service.\n•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.\nThere are 3 key elements of service delivery, namely:\n•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.\n•Digital surveillance where individuals need more frequent screening.\n•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts). \nOptical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance. \nThe Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.\nThe 7-year estimated contract values, based on predicted activity levels, are:\nLot 1 = £33,753,337, Lot 2 = £19,904,076, Lot 3 = £30,504,838, Lot 4 = £21,881,063, Lot 5 = £17,987,562\nPlease note, the full indicative contract values per each financial year can be found in the tender documentation.",
"classification": {
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
},
"mainProcurementCategory": "services"
},
"parties": [
{
"id": "GB-NHS-Y56",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI",
"locality": "Leeds",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom"
},
"details": {
"url": "https://www.england.nhs.uk"
},
"identifier": {
"id": "Y56",
"scheme": "GB-NHS",
"legalName": "NHS England"
},
"contactPoint": {
"name": "Khadijah Yasmin",
"email": "Khadijah.yasmin@nhs.net"
}
}
],
"language": "en",
"initiationType": "tender"
}30 Aug 2023 · 025408-2023 · tenderUpdate
{
"id": "025408-2023",
"tag": [
"tenderUpdate"
],
"date": "2023-08-30T10:00:52+01:00",
"ocid": "ocds-h6vhtk-03e155",
"buyer": {
"id": "GB-NHS-Y56",
"name": "NHS England"
},
"tender": {
"id": "PRJ1238",
"title": "NHS Diabetic Eye Screening Programme London Region",
"amendments": [
{
"id": "1",
"unstructuredChanges": [
{
"where": {
"label": "Short Description",
"section": "II.1.4"
},
"newValue": {
"text": "NHS England (London Region) (hereafter referred to as \"the Authority\") is seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.\nThis will be achieved by delivering an evidence-based service that:\n•Identifies the eligible population and ensures effective delivery with maximum coverage.\n•Is safe, effective, high quality, externally and independently monitored, and quality assured.\n•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.\n•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.\n•Has audit embedded in the service.\n•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.\nThere are 3 key elements of service delivery, namely:\n•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.\n•Digital surveillance where individuals need more frequent screening.\n•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).\nOptical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance.\nThe Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.\nThe 7-year estimated contract values, based on predicted activity levels, are:\nLot 1 = £33,703,069, Lot 2 = £19,862,595, Lot 3 = £30,920,240, Lot 4 = £21,533,552, Lot 5 = £18,120,336 \nPlease note, the full indicative contract values per each financial year can be found in the tender documentation."
},
"oldValue": {
"text": "NHS England (London Region) (hereafter referred to as \"the Authority\") is seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5).\nThe eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.\nThis will be achieved by delivering an evidence-based service that:\n•Identifies the eligible population and ensures effective delivery with maximum coverage.\n•Is safe, effective, high quality, externally and independently monitored, and quality assured.\n•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.\n•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.\n•Has audit embedded in the service.\n•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.\nThere are 3 key elements of service delivery, namely:\n•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.\n•Digital surveillance where individuals need more frequent screening.\n•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).\nOptical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance.\nThe Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.\nThe 7-year estimated contract values, based on predicted activity levels, are:\nLot 1 = £33,753,337, Lot 2 = £19,904,076, Lot 3 = £30,504,838, Lot 4 = £21,881,063, Lot 5 = £17,987,562\nPlease note, the full indicative contract values per each financial year can be found in the tender documentation."
}
},
{
"where": {
"label": "Estimated Value",
"section": "II.2.6"
},
"newValue": {
"text": "Value excluding VAT = £33,703,069"
},
"oldValue": {
"text": "Value excluding VAT: £33,753,337"
},
"relatedLot": "Lot 1"
},
{
"where": {
"label": "Estimated Value",
"section": "II.2.6"
},
"newValue": {
"text": "Value excluding VAT: £19,862,595"
},
"oldValue": {
"text": "Value excluding VAT: £19,904,076"
},
"relatedLot": "Lot 2"
},
{
"where": {
"label": "Estimated Value",
"section": "II.2.6"
},
"newValue": {
"text": "Value excluding VAT: £30,920,240"
},
"oldValue": {
"text": "Value excluding VAT: £30,504,838"
},
"relatedLot": "Lot 3"
},
{
"where": {
"label": "Estimated Value",
"section": "II.2.6"
},
"newValue": {
"text": "Value excluding VAT: £21,533,552"
},
"oldValue": {
"text": "Value excluding VAT: £21,881,063"
},
"relatedLot": "Lot 4"
},
{
"where": {
"label": "Estimated Value",
"section": "II.2.6"
},
"newValue": {
"text": "Value excluding VAT: £18,120,336"
},
"oldValue": {
"text": "Value excluding VAT: £17,987,562"
},
"relatedLot": "Lot 5"
},
{
"where": {
"label": "Time limit for receipt of tenders or requests to participate",
"section": "IV.2.2"
},
"newValue": {
"date": "2023-09-18T12:00:00+01:00"
},
"oldValue": {
"date": "2023-08-30T12:00:00+01:00"
}
}
]
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") is seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). \nThe eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.\nThis will be achieved by delivering an evidence-based service that:\n•Identifies the eligible population and ensures effective delivery with maximum coverage.\n•Is safe, effective, high quality, externally and independently monitored, and quality assured.\n•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.\n•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.\n•Has audit embedded in the service.\n•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.\nThere are 3 key elements of service delivery, namely:\n•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.\n•Digital surveillance where individuals need more frequent screening.\n•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts). \nOptical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance. \nThe Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.\nThe 7-year estimated contract values, based on predicted activity levels, are:\nLot 1 = £33,753,337, Lot 2 = £19,904,076, Lot 3 = £30,504,838, Lot 4 = £21,881,063, Lot 5 = £17,987,562\nPlease note, the full indicative contract values per each financial year can be found in the tender documentation.",
"classification": {
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
},
"mainProcurementCategory": "services"
},
"parties": [
{
"id": "GB-NHS-Y56",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI",
"locality": "Leeds",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom"
},
"details": {
"url": "https://www.england.nhs.uk"
},
"identifier": {
"id": "Y56",
"scheme": "GB-NHS",
"legalName": "NHS England"
},
"contactPoint": {
"name": "Khadijah Yasmin",
"email": "Khadijah.yasmin@nhs.net"
}
}
],
"language": "en",
"initiationType": "tender"
}12 Jul 2023 · 020027-2023 · tender
{
"id": "020027-2023",
"tag": [
"tender"
],
"date": "2023-07-12T17:07:18+01:00",
"ocid": "ocds-h6vhtk-03e155",
"buyer": {
"id": "GB-NHS-Y56",
"name": "NHS England"
},
"tender": {
"id": "PRJ1238",
"lots": [
{
"id": "1",
"title": "Lot 1 - North West London (NWL)",
"value": {
"amount": 33753337,
"currency": "GBP"
},
"status": "active",
"description": "Lot 1 - North West London (NWL) - Boroughs included - \nHillingdon, \nHammersmith and Fulham, \nKensington, \nChelsea and Westminster, \nEaling, \nHounslow, \nBrent and Harrow"
},
{
"id": "2",
"title": "Lot 2 - North Central London (NCL)",
"value": {
"amount": 19904076,
"currency": "GBP"
},
"status": "active",
"description": "Lot 2 - North Central London (NCL) - Boroughs included - \nBarnet, \nEnfield, \nHaringey,\n Islington and Camden"
},
{
"id": "3",
"title": "Lot 3 - North East London (NEL)",
"value": {
"amount": 30504838,
"currency": "GBP"
},
"status": "active",
"description": "Lot 3 - North East London (NEL) - Boroughs included - \nThe City and Hackney, \nWaltham Forest, Newham, \nTower Hamlets, \nBarking and Dagenham, \nHavering and Redbridge"
},
{
"id": "4",
"title": "Lot 4 - South East London (SEL)",
"value": {
"amount": 21881063,
"currency": "GBP"
},
"status": "active",
"description": "Lot 4 - South East London (SEL) - Boroughs included - \nLambeth, \nSouthwark, \nLewisham, \nBexley, \nBromley and Greenwich"
},
{
"id": "5",
"title": "Lot 5 - South West London (SWL)",
"value": {
"amount": 17987562,
"currency": "GBP"
},
"status": "active",
"description": "Lot 5 - South West London (SWL) Boroughs included - \nSutton and Merton, ,\nWandsworth, \nRichmond and Twickenham, \nCroydon and Kingston"
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
},
{
"id": "5",
"relatedLot": "5",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"additionalClassifications": [
{
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
}
]
}
],
"title": "NHS Diabetic Eye Screening Programme London Region",
"status": "active",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lotDetails": {
"maximumLotsBidPerSupplier": null,
"maximumLotsAwardedPerSupplier": 2
},
"description": "NHS England (London Region) (hereafter referred to as \"the Authority\") is seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). \nThe eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces.\nThe aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.\nThis will be achieved by delivering an evidence-based service that:\n•Identifies the eligible population and ensures effective delivery with maximum coverage.\n•Is safe, effective, high quality, externally and independently monitored, and quality assured.\n•Leads to earlier detection, appropriate referral, effective treatment and improved outcomes.\n•Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes.\n•Has audit embedded in the service.\n•Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.\nThere are 3 key elements of service delivery, namely:\n•Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance.\n•Digital surveillance where individuals need more frequent screening.\n•Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts). \nOptical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance. \nThe Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024.\nThe 7-year estimated contract values, based on predicted activity levels, are:\nLot 1 = £33,753,337, Lot 2 = £19,904,076, Lot 3 = £30,504,838, Lot 4 = £21,881,063, Lot 5 = £17,987,562\nPlease note, the full indicative contract values per each financial year can be found in the tender documentation.",
"tenderPeriod": {
"endDate": "2023-08-30T12:00:00+01:00"
},
"classification": {
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
},
"submissionTerms": {
"languages": [
"en"
]
},
"submissionMethod": [
"electronicSubmission"
],
"procurementMethod": "open",
"mainProcurementCategory": "services",
"submissionMethodDetails": "https://procontract.due-north.com/Advert?advertId=85b17dda-68d8-ed11-8121-005056b64545",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NHS-Y56",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UKI",
"locality": "Leeds",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom"
},
"details": {
"url": "https://www.england.nhs.uk",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"id": "Y56",
"scheme": "GB-NHS",
"legalName": "NHS England"
},
"contactPoint": {
"url": "https://procontract.due-north.com/Advert?advertId=85b17dda-68d8-ed11-8121-005056b64545",
"name": "Khadijah Yasmin",
"email": "Khadijah.yasmin@nhs.net"
}
}
],
"language": "en",
"description": "NHS England proposes an activity-based financial model with the following tariffs: \n•\tRoutine digital screening (RS001) - £39.10 per screen.\n•\tSlit lamp bio-microscopy (SLB003) - £48.29 per screen.\n•\tDigital surveillance (DS002) - £39.10 per screen.\n•\tPrisons screening (PS004) - £78.21 per screen.\n•\tForensics screening (FS005) - £58.65 per screen.\nThe Commissioner's ambition through the financial model is to encourage uptake of DESP to achieve or exceed the national achievable target of 85% uptake in routine screening (DE1).\nThe Services will be commissioned using the NHS DESP National Service Specification 23-24, localised where appropriate.\nNational changes to screening frequency for low-risk individuals are expected to be implemented during the contract term which will have an impact on activity. The subsequent impact on contract values will be agreed between the Provider and the Commissioner via contract variation. Activity projections used in this procurement do not account for these future changes as further clarity around timeline and implementation guidance is expected in the future. Further information is provided in the tender documentation.\nInterested providers may bid for one, multiple or all lots. However, if successful across multiple lots following evaluation, bidders will be awarded no more than two lots.\nThe Procurement is being managed by the NHS London Commercial Hub (NHS LCH) hosted by NEL ICB, on behalf of the Authority, in connection with a competitive Invitation to Tender (ITT) exercise that is being conducted via a process, based in part on the open procedure under the Public Contract Regulations 2015 (\"the Regulations\" (as amended)). \nThe Service falls within the scope of the Light Touch Regime (LTR) - Section 7 (Reg 74-76) of the Regulations governing procurement of Health, Social and related services listed under Schedule 3 of the Regulations. None of the references to \"Open procedure\", \"ITT\", the use of the term \"tender process\", or any other indication shall be taken to mean that the Authority intends to hold itself bound to any of the Regulations, save those applicable to LTR provisions.\nThe tendering process will be conducted in accordance with the requirements and flexibilities provided by Articles 74 to 76 of the Directive, and Regulations 74 to 76 of the Regulations. The Authority will run a transparent tender process, treating all Bidders equally. For the avoidance of doubt, the Authority will not be bound by the Regulations or the Treaty on the Functioning of the European Union or any other regulations or legislation except for the specific parts or circumstances that apply to the procurement of these Services.\nThe Contracting Authority intends to voluntarily observe the award decision notices provisions and 10-day standstill period described in Regulation 86 of the Regulations.",
"initiationType": "tender"
}